Telogen Effluvium: A Review.
Study Design
- 연구 유형
- Review
- 중재
- Telogen Effluvium: A Review.
- 대조군
- Placebo
- 효과 방향
- Neutral
- 비뚤림 위험
- Unclear
Abstract
Telogen effluvium was first described by Kligman in 1961. It is a most common cause of diffuse hair loss. Women with telogen effluvium more frequently present to dermatologist. A wide variety of potential triggers have been implicated in the pathogenesis of telogen effluvium. Diffuse shedding of telogen hair are seen after 3-4 months of triggering event. The observation of increased telogen hair shedding does not infer a cause. Establishing aetiology of telogen effluvium requires elicitation of relevant history and appropriate laboratory investigations to exclude endocrine, nutritional and autoimmune disorders.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
The Journal of investigative dermatology · 2003
Decreased serum ferritin is associated with alopecia in women.
Pediatrics · 2012
The diet factor in attention-deficit/hyperactivity disorder.
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
Sleep medicine clinics · 2015
Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.
International journal of dermatology · 2018